Home › Studies › PRJDB15956
PRJDB15956 DRP010254

Gut metagenomes in Parkinson's disease, Japan, case-control

Shotgun data in the gut of Parkinson's disease

167 gut shotgun metagenome samples from Japan (Nagoya and collaborating sites), comparing Parkinson's disease patients (94 samples) with healthy controls (73 samples) in a case-control design. machine-written summary

167 samples · 167 runs · JP · Age unknown · 2023 · 2.47 Gbp / sample

Sources
✓Sequence archive 1,336✓Abstract / description 167✓Full text 167–Supplementary tables✓External resources 167–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive1,336 sample values (collection date, country, health condition, health condition detail, latitude, location locality, location region, longitude)
✓ Abstract / description167 sample values (subject id)
✓ Full text167 sample values (antibiotic exposure) · PMC11109112
– Supplementary tablesno supplementary tables available (or none open access)
✓ External resources167 sample values (age) · from curatedMetagenomicData 3 (cMD 3)
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 sampling locations · 1 country
Age
elderly115
adult46
unknown6
Condition
neurological_psychiatric94
healthy_control73
Country
JP167
Body site
primary167
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 1 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 150 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 16 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 2.47 Gbp per sample0130Gbp
Community composition
Bifidobacterium 12.5%Bacteroides 6.6%Phocaeicola 5.5%Blautia_A 4.5%Faecalibacterium 4.5%Ruminococcoides 3.5%Roseburia 3.3%Streptococcus 3.1%Prevotella 3.0%Collinsella 2.5%Alistipes 2.1%Mediterraneibacter 2.0%not assigned to a genus 6.2%other genera 40.7%

Genera, mean relative abundance over 149 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category161 96%
country167 100%167
health_condition167 100%167
subject_id167 100%167
age_at_collection_days167 100%167
antibiotic_exposure167 100%167
collection_date167 100%167
detailed_location167 100%
health_condition_detail167 100%167
latitude167 100%167
location_locality167 100%167
location_region167 100%167
longitude167 100%167
Papers (1)
Details
Archive description

This is shotgun metagenome sequencing in the gut of Parkinson's disease patients. The sample size is 73 for healthy controls and 94 for Parkinson's disease. All studies were approved by the Ethical Review Committees of the Nagoya University Graduate School of Medicine (approval #2016-0151), Iwate Medical College Hospital (H28-123), Okayama Kyokuto Hospital (approval #kyoIR-2016002), and Fukuoka Medical College (approval #2016M027). We obtained written informed consent from all PD patients and healthy controls.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by opus_adjudicated with confidence 0.85. Assay shotgun_dna.

  • host study.description · “Parkinson's disease patients”
  • host run.host_tax_id · “9606”
  • body site study.title · “Shotgun data in the gut”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMD00618036age_at_collection_days20819.25R20.75external.cmd sourceage: 57; age_unit: Year; age_group: Adult
SAMD00618036antibiotic_exposurenoR30.70paper.body.methods_resultsWe also excluded subjects who claimed to have taken antibiotics in the last four weeks.
SAMD00618036collection_date2018-03-01R10.90biosample.attribute:collection_date2018-03-01
SAMD00618036countryJPR10.90sample.attr.geo_loc_nameJapan:Nagoya
SAMD00618036health_conditionhealthy_controlR10.70sample.name_rule:sample_titleI-C002AG
SAMD00618036health_condition_detailI-C002AGR10.70sample.name_rule:sample_titleI-C002AG
SAMD00618036latitude35.1815R10.90biosample.attribute:lat_lon35.1815 N 136.9066 E
SAMD00618036location_localityNagoyaR10.85biosample.attribute:geo_loc_nameJapan:Nagoya
SAMD00618036location_regionAichiR10.60biosample.attribute:lat_lon35.1815 N 136.9066 E
SAMD00618036longitude136.9066R10.90biosample.attribute:lat_lon35.1815 N 136.9066 E
SAMD00618036subject_idSAMD00618036R40.60design.one_sample_per_subject:descriptionThe sample size is 73 for healthy controls and 94 for Parkinson's disease.
Sequencing

167 runs over 167 samples · mean 2.49 Gbp per run (median 2.47 Gbp, total 415.89 Gbp; 167 runs with a base count) · layout PAIRED 167 · platform ILLUMINA 167 · models Illumina HiSeq 2500 (167) · 89% of runs with a Sandpiper profile · first public 2023-07-13 – 2023-07-16

Authors (0)

No author record.

Downloads

PRJDB15956.csv.gz (6.2 KB) · parquet (79.2 KB) — all 167 samples, every field with route and confidence · PRJDB15956_determinations.csv.gz (16.8 KB) — 1,837 evidence rows

Samples (167 · every field this project has values for · hover a cell for its source)
Loading the sample table…